Craneware plc

FAIRCRWRF · OTC · Healthcare
CRWRF·OTC·Healthcare
FAIR VALUE
Craneware plc
0.8%fair value
MARKET PRICE
$24.20
FAIR PRICE
$24.40
MARGIN
$0.20
UNDERVALUEDFAIROVERVALUED
P/E RATIO
24.9x
DIV. YIELD
1.87%
ROE
10.3%
MARKET CAP
$840M
FPI
fairpriceindex.com

FAIR PRICE VALUATION

0.8%fair value

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$24.20

FAIR PRICE

$24.40

MARGIN

$0.20

UNDERVALUEDFAIROVERVALUED

P/E Ratio

24.9x

What is P/E? →

Div. Yield

1.87%

ROE

10.3%

Average

Market Cap

$840M

Small-cap

NOW AVAILABLE

Get notified when CRWRF's fair price changes

Push notifications when CRWRF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

6.3/ 10

Low debt levels and consistent growth trajectory, but below-average fundamental quality.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$19.52CONSERVATIVE ENTRY
$24.40FAIR PRICE
$24.20MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$19.52

Fair price × 0.80

DISTANCE

19.3%

Price to entry level

At the current price of $24.20, CRWRF trades 19.3% above the conservative entry level of $19.52. This entry level represents a 20% margin of safety below the calculated fair price of $24.40 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate CRWRF's fair price

Craneware plc's fair price of $24.40 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $24.20, CRWRF trades 0.8% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting CRWRF's risk profile.

RELATIVE · 30%

Comparing CRWRF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for CRWRF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate CRWRF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for CRWRF.

Explore on Bulios

FAQ

What is the fair price of CRWRF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Craneware plc is $24.40. At the current market price of $24.20, CRWRF trades 0.8% below its calculated fair value.

Is CRWRF overvalued or undervalued?+

Craneware plc is currently fair based on our valuation model. The stock trades at $24.20, which is 0.8% below the fair price of $24.40. The P/E ratio of 24.9x is a key metric in the valuation.

What is the margin of safety for CRWRF?+

With a 20% margin of safety applied to the fair price of $24.40, the conservative entry level for CRWRF is $19.52. At the current market price of $24.20, the stock trades 19.3% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is CRWRF's fair price updated?+

We update fair price calculations for CRWRF daily after market close. The current fair price of $24.40 incorporates the latest market data and sector multiples.

What factors affect CRWRF's fair price calculation?+

CRWRF's fair price of $24.40 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 24.9x, ROE of 10.3%, and dividend yield of 1.87%.

Is CRWRF a good buy right now?+

At $24.20, CRWRF trades 0.8% below our fair value estimate of $24.40. The stock is currently fair. ROE stands at 10.3% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does CRWRF pay dividends?+

CRWRF has a dividend yield of 1.87%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.